BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34052817)

  • 1. Hypocretin/Orexin, Sleep and Alzheimer's Disease.
    Dauvilliers Y
    Front Neurol Neurosci; 2021; 45():139-149. PubMed ID: 34052817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid β and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A(1) receptor.
    Liu Z; Wang F; Tang M; Zhao Y; Wang X
    Int J Mol Med; 2019 Jan; 43(1):435-442. PubMed ID: 30365112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the sleep-amyloid interactions in Alzheimer's disease pathogenesis.
    Ning S; Jorfi M
    J Neurophysiol; 2019 Jul; 122(1):1-4. PubMed ID: 30864847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.
    Wang C; Holtzman DM
    Neuropsychopharmacology; 2020 Jan; 45(1):104-120. PubMed ID: 31408876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep-Wake Disorders in Alzheimer's Disease: A Review.
    Sun YY; Wang Z; Zhou HY; Huang HC
    ACS Chem Neurosci; 2022 May; 13(10):1467-1478. PubMed ID: 35507669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease.
    Roh JH; Jiang H; Finn MB; Stewart FR; Mahan TE; Cirrito JR; Heda A; Snider BJ; Li M; Yanagisawa M; de Lecea L; Holtzman DM
    J Exp Med; 2014 Dec; 211(13):2487-96. PubMed ID: 25422493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glymphatic dysfunction and sleep disorders: indirect effects on Alzheimer's disease].
    Kashchenko SA; Eranova AA; Chuguy EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):7-12. PubMed ID: 38676671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-β, and Sleep.
    Boespflug EL; Iliff JJ
    Biol Psychiatry; 2018 Feb; 83(4):328-336. PubMed ID: 29279202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin and Alzheimer's Disease.
    Liguori C
    Curr Top Behav Neurosci; 2017; 33():305-322. PubMed ID: 28012089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.
    Arias-Carrión O; Bradbury M
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):232-4. PubMed ID: 19689304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of hypocretins/orexins in sleep disorders and narcolepsy.
    Brown RE
    Drug News Perspect; 2003 Mar; 16(2):75-9. PubMed ID: 12792667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease pathogenesis: The role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes.
    Havekes R; Heckman PRA; Wams EJ; Stasiukonyte N; Meerlo P; Eisel ULM
    Cell Signal; 2019 Dec; 64():109420. PubMed ID: 31536750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.
    Kang JE; Lim MM; Bateman RJ; Lee JJ; Smyth LP; Cirrito JR; Fujiki N; Nishino S; Holtzman DM
    Science; 2009 Nov; 326(5955):1005-7. PubMed ID: 19779148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep-wake regulation and the hallmarks of the pathogenesis of Alzheimer's disease.
    Van Egroo M; Narbutas J; Chylinski D; Villar González P; Maquet P; Salmon E; Bastin C; Collette F; Vandewalle G
    Sleep; 2019 Apr; 42(4):. PubMed ID: 30649520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypocretin/orexin system in health and disease.
    Nishino S
    Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.
    Morrone CD; Raghuraman R; Hussaini SA; Yu WH
    Mol Neurodegener; 2023 Apr; 18(1):27. PubMed ID: 37085942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Gao F; Liu T; Tuo M; Chi S
    Neurosci Lett; 2021 Nov; 765():136247. PubMed ID: 34530113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease.
    Cedernaes J; Osorio RS; Varga AW; Kam K; Schiöth HB; Benedict C
    Sleep Med Rev; 2017 Feb; 31():102-111. PubMed ID: 26996255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurobiological underpinning of the circadian wake signal.
    Zeitzer JM
    Biochem Pharmacol; 2021 Sep; 191():114386. PubMed ID: 33359009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis.
    Treu SP; Plante DT
    Sleep Med; 2021 Sep; 85():230-238. PubMed ID: 34364094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.